$21.29
2.14% today
Nasdaq, Feb 28, 05:18 pm CET
ISIN
US8753722037
Symbol
TNDM

Tandem Diabetes Care, Inc. Stock price

$21.75
-14.82 40.53% 1M
-23.82 52.27% 6M
-14.27 39.62% YTD
-5.59 20.45% 1Y
-90.88 80.69% 3Y
-53.30 71.02% 5Y
-95.25 81.41% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
-11.84 35.25%
ISIN
US8753722037
Symbol
TNDM
Sector

Key metrics

Market capitalization $1.43b
Enterprise Value $1.46b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF 293.33
EV/Sales (TTM) EV/Sales 1.56
P/S ratio (TTM) P/S ratio 1.52
P/B ratio (TTM) P/B ratio 5.48
Revenue growth (TTM) Revenue growth 25.74%
Revenue (TTM) Revenue $940.20m
EBIT (operating result TTM) EBIT $-99.13m
Free Cash Flow (TTM) Free Cash Flow $4.99m
Cash position $438.33m
EPS (TTM) EPS $-1.47
P/E forward negative
P/S forward 1.42
EV/Sales forward 1.45
Short interest 16.33%
Show more

Is Tandem Diabetes Care, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Tandem Diabetes Care, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Tandem Diabetes Care, Inc. forecast:

16x Buy
73%
5x Hold
23%
1x Sell
5%

Analyst Opinions

22 Analysts have issued a Tandem Diabetes Care, Inc. forecast:

Buy
73%
Hold
23%
Sell
5%

Financial data from Tandem Diabetes Care, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
940 940
26% 26%
100%
- Direct Costs 451 451
19% 19%
48%
490 490
33% 33%
52%
- Selling and Administrative Expenses 373 373
11% 11%
40%
- Research and Development Expense 199 199
17% 17%
21%
-83 -83
41% 41%
-9%
- Depreciation and Amortization 17 17
6% 6%
2%
EBIT (Operating Income) EBIT -99 -99
36% 36%
-11%
Net Profit -96 -96
57% 57%
-10%

In millions USD.

Don't miss a Thing! We will send you all news about Tandem Diabetes Care, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Tandem Diabetes Care, Inc. Stock News

Negative
Seeking Alpha
about 23 hours ago
Tandem Diabetes Care, Inc. released its Q4 and full-year 2024 earnings after the bell yesterday, and the market has given the stock the thumbs down. Shares are down >30% in trading today, despite a beat on revenues of $940m, and on EPS, with a return to positive cash flow. Guidance for 2025 is for revenues of ~$1bn — the growth rate does not seem to have impressed Wall Street, and Q4 underperfo...
Neutral
Seeking Alpha
one day ago
Tandem Diabetes Care, Inc. (NASDAQ:TNDM ) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ET Company Participants Susan Morrison - Executive Vice President & Chief Administrative Officer John Sheridan - President & Chief Executive Officer Mark Novara - Executive Vice President & Chief Commercial Officer Leigh Vosseller - Executive Vice President & Chief Financial Officer Conference C...
Neutral
Business Wire
2 days ago
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today reported its financial results for the quarter and fiscal year ended December 31, 2024 and provided its financial guidance for the year ending December 31, 2025. Fourth Quarter 2024 Financial Highlights compared to Fourth Quarter 2023 Achieved record sales as w...
More Tandem Diabetes Care, Inc. News

Company Profile

Tandem Diabetes Care, Inc. engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. Its flagship product, t:slim X2 Insulin Delivery System, operates as a small insulin pump. The company was founded by Paul M. DiPerna on January 27, 2006 and is headquartered in San Diego, CA.

Head office United States
CEO John Sheridan
Employees 2,650
Founded 2006
Website www.tandemdiabetes.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today